Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

Assessing Patient Engagement and Understanding in Hepatic Encephalopathy Clinical Research

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06201988

Enrollment

500

Registered

2024-01-11

Start date

2025-01-31

Completion date

2027-01-31

Last updated

2024-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Encephalopathy

Keywords

Hepatic Encephalopathy

Brief summary

This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in hepatic encephalopathy clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors. In essence, this trial aims to deepen understanding of the factors influencing participation in hepatic encephalopathy clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Signed Written Informed Consent * Aged ≥ 18 years old * No prior treatment for hepatic encephalopathy

Exclusion criteria

* Participant is actively receiving study therapy in another * Inability to provide written informed consent * Women of childbearing potential without a negative pregnancy test; or women who are lactating.

Design outcomes

Primary

Measure	Time frame
Rate of patients who decide to join in a hepatic encephalopathy clinical trial	3 months
Number of hepatic encephalopathy patients who remain in clinical trial until completion	12 months

Countries

United States

Contacts

Primary ContactMichael B Gill

bask@withpower.com(415) 900-4227

Outcome results